Trial | NCT02136342  Report issue

Title

Phase 1 Trial of Chlorogenic Acid in Patients With Advanced Cancer
Phase 1 Trial Evaluating Tolerability and Pharmacokinetics of Chlorogenic Acid for Injection in Patients With Advanced Cancer

  • Phase

    Phase 1

  • Study Type

    Interventional

  • Status

    Terminated

  • Study Participants

    None
The purpose of the study is to explore if chlorogenic acid is safe in patients with cancer.
Study Started
May 31
2014
Primary Completion
Aug 31
2015
Anticipated
Last Update
Oct 21
2014
Estimate

Drug chlorogenic acid

chlorogenic acid Experimental

Criteria 

Inclusion Criteria:

advanced cancer with no effective treatment
Karnofsky performance status no less than 70
adequated organ function
informed consent

Exclusion Criteria:

allergic to chlorogenic acid
persistent toxicities from previous treatment (no less than grade 2)
No Results Posted